{"acquisitions":[],"changes":[],"country":"US","description":"Adjuvax develops saponin-based vaccine adjuvants designed to strengthen immune responses to vaccines. It serves vaccine manufacturers and developers, including those targeting immunocompromised populations. Its differentiator is potent, cost-effective, structurally defined adjuvants with diverse activity profiles from new formulations.","domain":"adjuvax.net","employees":null,"founded":2018,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":33.502894,"lng":-86.797669,"location":"Hoover, Alabama","multiples":[],"name":"Adjuvax LLC","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":3000000,"connectionsAmong":[],"currency":"USD","date":"2025-01-01","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"adjuvax-net-2025-01-01-grant","source":{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-02","status":"attributed","url":null},"status":"attributed","type":"grant","url":null}],"slug":"adjuvax-net","sources":[{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-02","status":"attributed","url":null},{"fact":"existence","publisher":"adjuvax.net","retrievedAt":"2026-05-02","status":"self-reported","url":"https://adjuvax.net"},{"fact":"description","publisher":"adjuvax.net","retrievedAt":"2026-05-02","status":"self-reported","url":"https://adjuvax.net"}],"stage":null,"stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":["Cloudflare","WordPress 7.0","LiteSpeed","LiteSpeed Cache","Parsley.js","PHP","WordPress Block Editor","MySQL","jquery 3.7.1","bootstrap 5.0.1"],"totalRaisedUsd":3000000,"traction":[],"updatedAt":"2026-05-02","valuations":[]}